| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.7 | 0.008 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.008 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |